Dr. Levy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-919-2900Fax+1 617-730-0255
Summary
- Dr. Ofer Levy is a pediatric infectious disease specialist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital (BCH) and Brigham and Women's Hospital. He received his medical degree from NYU Grossman School of Medicine and has been in practice 20 years. He directs the Precision Vaccines Program at BCH and serves on the U.S. FDA Vaccines & Related Biologic Products Advisory Committee. He has 180 publications and a Google Scholar H index of 63. Dr. Levy and his research have been featured on CNN, FOXNews, NBC, the New York Times, USA Today and Scientific American.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2000 - 2003
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1997 - 2000
- New York University School of MedicineClass of 1997
Certifications & Licensure
- MA State Medical License 2003 - 2026
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Berson Research Award New York University School of Medicine, 2018
Clinical Trials
- Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity Start of enrollment: 2017 Sep 06
Publications & Presentations
PubMed
- Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19.Cole Maguire, Jing Chen, Nadine Rouphael, Harry Pickering, Hoang Van Phan
Biorxiv. 2024-11-16 - 1 citationsNeed for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl.Elissa R Weitzman, Sydney E Pierce, Laura M Blakemore, Andrew Murdock, Asimenia Angelidou
Vaccine. 2024-10-24 - Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.Avy Violari, Kennedy Otwombe, William Hahn, Shiyu Chen, Deirdre Josipovic
Medrxiv. 2024-10-17
Journal Articles
- Increasing FIM2/3 Antigen-Content Improves Efficacy of Bordetella Pertussis Vaccines in Mice in Vivo Without Altering Vaccine-Induced Human Reactogenicity Biomarkers i...Ofer Levy, MD, ScienceDirect
Press Mentions
- Model Enables Study of Age-Specific Responses to COVID mRNA Vaccines in a DishDecember 12th, 2024
- 5 Ways RFK Jr. Could Undermine Lifesaving Childhood VaccinesNovember 19th, 2024
- HMN 2024: In Vitro Model Enables Study of Age-Specific Responses to COVID mRNA VaccinesNovember 16th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: